AzTrials
AzTrials

Pleural EffusionCLIN-ECHO-INCT05280119

Efficacy of the echOpen Device to Identify Effusion and to Detect Basilic Vein

A study testing EchOpen ultra-portable ultrasound device, Ultrasound device routinely used in the department. and Standard ultrasound examination by an independent referent radiologist in people with Pleural Effusion and Abdominal Effusion, run by Assistance Publique - Hôpitaux de Paris at 4 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In recent years, portable and ultra-portable ultrasound devices are increasingly used by the non radiologists, notably cardiologists or obstetrician gynecologist, at the patient's bedside to visualize and measure anatomical structures and fluid and provide the clinical examination with additional signs allowing… Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
EchOpen ultra-portable ultrasound device, Ultrasound device routinely used in the department. and Standard ultrasound examination by an independent referent radiologist
Could I receive a placebo?
No, everyone receives an active treatment
How many people
201 participants
Where
4 sitesFrance
Study dates
4 Apr 2022to 19 Aug 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult patient (age ≥ 18 years old)
  • Patient having signed the informed consent to participate in this clinical investigation
  • Patient affiliated to the social security scheme
  • Patient arriving in the hospital clinical ward (own initiative or by emergency services) whose clinical symptomatology (e.g. dyspnea, thoracic pain, etc.) suggests the presence of pathological elements (effusion) which would be visible using an ultrasound probe
  • Patient consulting in the hospital clinical ward who could potentially benefit from a basilic vein line placement using an ultrasound device

Who cannot join

  • Minor patient (age < 18 years)
  • Patients under the "State medical assistance"
  • Obese patient (body mass index > 29.9)
  • Patient in too serious condition for the clinical examination to be done fully and/or with additional exploratory time
  • Unstable patient: need for immediate care, impossibility to carry out a thorough clinical examination including interview, palpation, auscultation, percussion
  • Known allergy to ultrasound gel

Trial locations and contacts

4 sites in 1 country.

France4 sites
  • Avicenne Hospital - APHP - Hepatology Department

    Bobigny, 93140

  • Cochin Hospital - APHP - Emergency Department

    Paris, 75014

  • Cochin Hospital - APHP - Pneumology department

    Paris, 75014

  • Paul Brousse Hospital - APHP - Hepatobiliary Center

    Villejuif, 94800

Other trials in France

About this study

Official title: Assessment of the echOpen Ultra-portable Ultrasound Device in Daily Use by Clinicians. Part I: Identification of Effusion and Detection of Basilic Vein

In recent years, portable and ultra-portable ultrasound devices are increasingly used by the non radiologists, notably cardiologists or obstetrician gynecologist, at the patient's bedside to visualize and measure anatomical structures and fluid and provide the clinical examination with additional signs allowing quicker and more confident clinical decisions.

This innovative approach is slowed down by the accessibility of these miniaturized devices, the price of which remains high.

Read more

The echOpen device includes an ultra-portable ultrasound probe and a mobile application that allows the image to be displayed on a smartphone via a WIFI protocol.

The objective of the clinical investigation is to show that the echOpen device, using three frequencies 3.5 Mhz, 5.0 Mhz and 7.5 Mhz, allows identifying the semiological signs or anatomical structures of interest located at several depths of the body, with a performance similar to other devices routinely used in clinical departments.

Read the detailed description

The echOpen device includes an ultrasound probe and a mobile application. The mechanical probe emits at three ultrasound frequencies, 3.5 Mhz, 5.0 Mhz and 7.5 Mhz, which allows the exploration of the interior of the body at different depths in a non-invasive and non-irradiating manner.

Thus, the purpose of the echOpen device is, on one hand, to guide the diagnosis during the clinical examination and, on the other hand, to identify anatomical structures in order to assist in management.

The objective of the clinical investigation is to demonstrate that the echOpen device is able to identify semiological signs and localize anatomical structures at different depths of the body, with a performance not inferior to that of other ultrasound devices, routinely employed in hospital clinical departments.

The signs of interest (i.e. search for an intra-abdominal (3.5 Mhz) and pleural (5.0 Mhz) effusion) were chosen for their clinical usefulness (their presence during the clinical examination constitutes an argument for orientation and/or severity) and for their prevalence in the study population.

The identification of anatomical structure of interest (i.e. detection of basilic vein (7.5Mhz)) was chosen because it is a gesture frequently used when taking in charge of a patient hospitalized in the selected departments.

An ultrasound probe in use in the hospital clinical departments where the investigation takes place will be employed as a comparator to judge the performance of the echOpen device.

This clinical investigation is part of a CE marking procedure.

Being tested
EchOpen ultra-portable ultrasound device, Ultrasound device routinely used in the department., Standard ultrasound examination by an independent referent radiologist
Keywords
Ultrasound, Ultrasonography, Point-of-care-ultrasound, Pleural Effusion, Abdominal Effusion, Basilic vein
Medical subject headings
Pleural Effusion

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • EchOpen ultra-portable ultrasound deviceDevice

    Depending on the clinical picture, patients are examined to detect the presence or absence of pleural effusion, or intra-abdominal effusion, or to localize the basilic vein

  • Ultrasound device routinely used in the department.Device

    Patients who were first examined with the EchOpen ultra-portable ultrasound device, are secondarily examined with an ultrasound probe used routinely in the department.

  • Standard ultrasound examination by an independent referent radiologistProcedure or surgery

    In a case of discordance between the assessments made with echOpen and the usual ultrasound device, an independent referent radiologist will use a standard ultrasound machine to constitute the gold standard (GS) rating

Study groups in NCT05280119
Study groupRoleWhat they receive
Patients benefitting ultrasound examinationExperimentalThis is the only arm of the study. Patients with an indicative clinical picture that leads the clinician to resort to the use of an ultrasound to potentially support the diagnosis will be examined to verify the presence of pleural effusion or intra-abdominal effusion, or to identify basilic vein. The patients will be assessed first with the echOpen device and second witn an ultrasound routinely used in the department. In a case of discordance between the assessments made with echOpen and the usual ultrasound device, an independent referent radiologist will use a standard ultrasound machine to constitute the gold standard (GS) rating
Receives: Device: EchOpen ultra-portable ultrasound device; Device: Ultrasound device routinely used in the department.; Procedure: Standard ultrasound examination by an independent referent radiologist

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Presence of Pleural effusion

    Presence or absence of pleural effusion as assessed by the echOpen device or by a portable ultrasound routinely used in the department

    Measured: Day 0

  2. Presence of Intra-abdominal effusion

    Presence or absence of intra-abdominal effusion as assessed by the echOpen device or by a portable ultrasound routinely used in the department

    Measured: Day 0

  3. Basilic vein identification

    Successful identification of the basilic vein using the echOpen device or a portable ultrasound routinely used in the department

    Measured: Day 0

Secondary outcomes (3)
  1. Plural effusion detected using a gold standard procedure

    Presence of pleural effusion determined by an independent referent radiologist using a standard ultrasound machine

    Measured: Day 0

  2. Intra-abdominal effusion detected using a gold standard procedure

    Presence or absence of intra-abdominal effusion determined by an independent referent radiologist using a standard ultrasound machine

    Measured: Day 0

  3. Basilic vein identification using a gold standard procedure

    Identification of the basilic vein by an independent referent radiologist using a standard ultrasound machine

    Measured: Day 0

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Mar 2022
  2. Study start4 Apr 2022
  3. Primary completion19 Aug 2022
  4. Study completion19 Aug 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Screening
Allocation
Not applicable
Intervention model
Single group
Model description
A single group, comparative, non-randomized, controlled study. Each patient represents her/his own control: the patient is examined consecutively with the echOpen probe, then with the probe used in the department
Masking
None (open label)
Enrolment
201 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05280119
Sponsor's protocol ID
APHP210065
Other IDs
2021-A00341-40
Acronym
CLIN-ECHO-I
Status last verified
Dec 2022
First submitted
4 Mar 2022
Last updated
8 Dec 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing EchOpen ultra-portable ultrasound device, Ultrasound device routinely used in the department. and Standard ultrasound examination by an independent referent radiologist in people with Pleural Effusion and Abdominal Effusion, run by Assistance Publique - Hôpitaux de Paris at 4 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Dec 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Presence of Pleural effusion (time frame: Day 0). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Dec 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in